What’s the outlook (the prognosis) for using CAR T-cell therapy for lymphoma and other blood cancers?

Early results of CAR T-cell therapy for treating lymphoma and other blood cancers are highly promising and exciting. Many patients whose blood cancers returned or in whom other standard treatments failed achieved complete success (no signs of cancer) with CAR T-cell therapy. However, to confirm the early success of this therapy, longer term trials that enroll larger numbers of patient are needed. Larger trials will also help further identify the side effects of this therapy and ways to best manage them.

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy